Tricolorin A, (11 S )‐11‐hydroxyhexadecanoic acid 11‐ O ‐ α ‐ l ‐ rhamnopyranosyl‐(1?3)‐ O ‐ α ‐ l ‐{2‐ O ‐(2 S ‐methylbutanoyl)‐4‐ O ‐(2 S ‐methylbutanoyl)}‐rhamnopyranosil‐(1?2)‐ O ‐ β ‐ d ‐glucopyranosil‐(1?2)‐ β ‐fucopyranoside‐(1,3′′‐lactone), the major phytogrowth inhibitor isolated from Ipomoea tricolor Cav. (Convolvulaceae) was found to be a potent uncoupler (U 50 =0.33 μ M ) of photophosphorylation in spinach chloroplasts. Tricolorin A inhibited H + ‐uptake and adenosine 5′‐triphosphate (ATP) synthesis, and stimulated basal and phosphorylating electron flows. Using a combination of two well‐known fluorescent ΔpH probes, 9‐aminoacridine and 9‐amino‐6‐chloro‐2‐methoxyacridine, the uncoupling behavior of tricolorin A was also demonstrated for submitochondrial particles. Polarographic data showed that high concentrations (20 μ M ) of tricolorin A inhibited photosystem II (PSII) electron flow at the level of plastoquinone B (Q B ). Chlorophyll (Chl) a fluorescence analysis showed that tricolorin A induced accumulation of Q A − and strongly decreased the electron transport capacity, suggesting that the target of this molecule was located at the Q B level. The macrocyclic lactone‐type structure of this allelopathic agent proved to be an important structural requirement for uncoupling activity since its hydrolysis caused loss of the inhibitory potential.
No takes yet. Share an insight, caveat, or question.
Achnine et al. (1999) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: